Borrower(s) | Expiration | Capacity | Letters of Credit Issued | Drawdowns | Unused Commitments | |||||||||||||
(In millions) | ||||||||||||||||||
MetLife, Inc. and MetLife Funding, Inc. | September 2017 (1) | $ | 1,000 | $ | 59 | $ | — | $ | 941 | |||||||||
MetLife, Inc. and MetLife Funding, Inc. | August 2016 (2) | 3,000 | 133 | — | 2,867 | |||||||||||||
Total | $ | 4,000 | $ | 192 | $ | — | $ | 3,808 |
(1) | In September 2012, MetLife, Inc. and MetLife Funding, Inc. entered into a $1.0 billion five-year credit agreement which amended and restated the three-year agreement dated October 2010. All borrowings under the 2012 five-year credit agreement must be repaid by September 2017, except that letters of credit outstanding on that date may remain outstanding until no later than September 2018. MetLife, Inc. incurred costs of $4 million related to the amended and restated credit facility, which were capitalized and included in other assets. These costs are being amortized over the remaining term of the amended and restated credit facility. |
(2) | In connection with the October 2013 re-domestication of Exeter to Delaware in anticipation of the Mergers and the related redistribution of assets held in trust at Exeter, $1.9 billion of outstanding letters of credit were no longer required and therefore canceled by the Company. Accordingly, remaining availability under the unsecured credit facilities increased by $1.9 billion in October 2013. See Note 8 for further information on the Mergers. |